CN104557922A - Synthetic method for 6-bromoimidazo[1,2-a]pyridine-8-carboxylic acid - Google Patents
Synthetic method for 6-bromoimidazo[1,2-a]pyridine-8-carboxylic acid Download PDFInfo
- Publication number
- CN104557922A CN104557922A CN201410846459.3A CN201410846459A CN104557922A CN 104557922 A CN104557922 A CN 104557922A CN 201410846459 A CN201410846459 A CN 201410846459A CN 104557922 A CN104557922 A CN 104557922A
- Authority
- CN
- China
- Prior art keywords
- pyridine
- formic acid
- bromine imidazo
- preparation
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000010189 synthetic method Methods 0.000 title claims abstract description 9
- XPFDJWFDQORPQO-UHFFFAOYSA-N 6-bromoimidazo[1,2-a]pyridine-8-carboxylic acid Chemical compound OC(=O)C1=CC(Br)=CN2C=CN=C12 XPFDJWFDQORPQO-UHFFFAOYSA-N 0.000 title abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000012043 crude product Substances 0.000 claims abstract description 27
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000002904 solvent Substances 0.000 claims abstract description 22
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 16
- KPIVDNYJNOPGBE-UHFFFAOYSA-N 2-aminonicotinic acid Chemical compound NC1=NC=CC=C1C(O)=O KPIVDNYJNOPGBE-UHFFFAOYSA-N 0.000 claims abstract description 13
- QSKPIOLLBIHNAC-UHFFFAOYSA-N 2-chloro-acetaldehyde Chemical compound ClCC=O QSKPIOLLBIHNAC-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 13
- 239000000047 product Substances 0.000 claims abstract description 9
- 239000003513 alkali Substances 0.000 claims abstract description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 24
- 229910052794 bromium Inorganic materials 0.000 claims description 24
- WHOCKNWCRFHEMH-UHFFFAOYSA-N imidazo[1,2-a]pyridine-8-carboxylic acid Chemical compound OC(=O)C1=CC=CN2C=CN=C12 WHOCKNWCRFHEMH-UHFFFAOYSA-N 0.000 claims description 21
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- IEPDTLRHISNBLB-UHFFFAOYSA-N 2-amino-5-bromopyridine-3-carboxylic acid Chemical compound NC1=NC=C(Br)C=C1C(O)=O IEPDTLRHISNBLB-UHFFFAOYSA-N 0.000 claims description 12
- 238000001953 recrystallisation Methods 0.000 claims description 10
- 238000000967 suction filtration Methods 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 8
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 7
- 235000017550 sodium carbonate Nutrition 0.000 claims description 7
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 3
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 2
- 235000015320 potassium carbonate Nutrition 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 1
- UTCSSFWDNNEEBH-UHFFFAOYSA-N imidazo[1,2-a]pyridine Chemical compound C1=CC=CC2=NC=CN21 UTCSSFWDNNEEBH-UHFFFAOYSA-N 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 9
- 238000001816 cooling Methods 0.000 description 8
- 238000002390 rotary evaporation Methods 0.000 description 8
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- DOGXPDFZEQXZDS-UHFFFAOYSA-N imidazo[1,2-a]pyridine-3-carboxylic acid Chemical compound C1=CC=CN2C(C(=O)O)=CN=C21 DOGXPDFZEQXZDS-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- WGOLHUGPTDEKCF-UHFFFAOYSA-N 5-bromopyridin-2-amine Chemical compound NC1=CC=C(Br)C=N1 WGOLHUGPTDEKCF-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical class [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The invention belongs to the field of organic synthesis and particularly relates to a synthetic method for 6-bromoimidazo[1,2-a]pyridine-8-carboxylic acid. The method comprises the following steps: reacting 2-aminonicotinic acid with N-bromobutanimide at subzero 8-35 DEG C in the presence of a solvent in proportion, reacting with chloroacetaldehyde at 30-130 DEG C, adding alkali, dropwise adding concentrated hydrochloric acid until the pH value is 3-6, and obtaining a crude product, wherein cotton-wool-shaped materials are generated in the dropwise-adding process; re-crystallizing by water and ethanol in proportion to obtain a pure product. The reaction raw materials are easily available and reasonable in price; the method is mild in reaction condition, easy to carry out and simple in post-treatment; moreover, the product is stable in quality and high in purity.
Description
(1) technical field
The invention belongs to organic synthesis field, be specifically related to a kind of synthetic method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid.
(2) background technology
6-bromine imidazo [1,2-a] pyridine-8-formic acid is the important intermediate of organic synthesis, is mainly used in medicine intermediate, organic synthesis, organic solvent, also can be applicable to the aspects such as DYE PRODUCTION, pesticide producing and spices.
This medicine intermediate is more novel, has very large using value.
Disclose a kind of synthetic method of 6-bromine imidazo [1,2-a] pyridine-3-formic acid in August 6 in 2014, comprise the following steps:
N, N-dimethylformamide dimethyl and 2-amino-5-bromopyridine react at 40-100 DEG C, under alkali effect, in certain solvent, react at 60-160 DEG C with ethyl bromoacetate, then under alkali effect, hydrolysis reaction 1-5 hour, reaction terminates, neutralize through hydrochloric acid, filter, wash, dry direct must 6-bromine imidazo [1,2-a] pyridine-3-formic acid sterling.
(3) summary of the invention
The present invention is in order to make up the deficiencies in the prior art, and provide the synthetic method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid, this synthetic method is simple to operate, productive rate is high, is applicable to laboratory and suitability for industrialized production.
The present invention is achieved through the following technical solutions:
A kind of synthetic method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid, its special character is: comprise the following steps:
(1) 2-amino-nicotinic acid and N-bromo-succinimide are in certain ratio, at certain solvent, react under subzero 8-35 degree Celsius, obtained 2-amino-5-bromo-nicotinic acid, and this intermediate does not need to purify;
(2) react at 30-130 DEG C generates 6-bromine imidazo [1,2-a] pyridine-8-formic acid with a certain proportion of monochloroacetaldehyde. hydrochloride, reaction terminates, and is down to room temperature, then puts into refrigerator and continues to lower the temperature, product precipitation, the thick product of low temperature suction filtration;
(3) this thick product water dissolves add alkali completely, then drips concentrated hydrochloric acid to pH value to 3-6, has flocculence produce raw, obtain crude product in dropping process; Use the sterling of water and ethanol certain proportion recrystallization again.
The preparation method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid of the present invention, said solvent is ethyl acetate, ethanol, DMF, acetonitrile and N,N-dimethylacetamide.
The preparation method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid of the present invention, said alkali is saleratus, salt of wormwood, sodium bicarbonate, sodium carbonate.
The preparation method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid of the present invention, said proper temperature is 40 DEG C, 50 DEG C, 60,70 DEG C and 80 DEG C.
The preparation method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid of the present invention, the certain proportion of said 2-amino-nicotinic acid and N-bromo-succinimide refers to 1:1.05,1:1.1,1:1.15,1:1.2,1:1.25.
The preparation method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid of the present invention, said 2-amino-5-bromo-nicotinic acid and monochloroacetaldehyde certain proportion are 1:1,1:1.15,1:1.2,1:1.25,1:3.
The preparation method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid of the present invention, the certain proportion of said water and ethanol is 1:1,1.5:1,2:1,1:1.5,1:2.
The preparation method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid of the present invention, step (1) reaction times is 3-10 hour, and step (1) reaction times is 6-12 hour.
Its reaction is:
Beneficial effect of the present invention: reaction raw materials compares and is easy to get, reasonable price, reaction conditions is gentle, easy handling, is easy to control, and aftertreatment is simple, and constant product quality, purity is high.
(4) embodiment
Embodiment 1
2-amino-nicotinic acid (20.7g, 150mmol) and N-bromo-succinimide (28.04g, 157.5mmol) make solvent by ethyl acetate, react 6 hours under subzero 5-10 degree Celsius, obtained 2-amino-5-bromo-nicotinic acid; Rotary evaporation removes unnecessary solvent, adds the aqueous chloroacetaldehyde solution of 165mmol (32.38g) 40%, and 40 DEG C are reacted 10 hours, and reaction terminates, and be chilled to room temperature, then put into refrigerator and continue cooling 4 hours, cold-draw filters to obtain crude product.Dissolve crude product with saturated potassium bicarbonate aqueous solution, then drip concentrated hydrochloric acid, regulate pH value to 3-6, have flocculence produce raw in dropping process, dropwise latter standing 6 hours, suction filtration, washs to obtain crude product.Carry out recrystallization with water and ethanol 1:1 and obtain sterling 22.85g, productive rate 63.2%, fusing point: 110.5-112.0 DEG C, nuclear magnetic resonance spectroscopy:
1HNMR(400MHzCDCl3):11.0(s,1H),8.87(s,1H),7.62(d,J=8.0Hz,1H),7.48(s,1H), 7.37(q,J=8.0Hz,2H)。
Embodiment 2
2-amino-nicotinic acid (27.6g, 200mmol) and N-bromo-succinimide (NBS) (39.16g, 220mmol) ethanol as solvent, react 3 hours under subzero 8 degrees Celsius, obtained 2-amino-5-bromo-nicotinic acid; Rotary evaporation removes unnecessary etoh solvent, adds the aqueous chloroacetaldehyde solution of 230mmol (45.14g) 40%, and 50 DEG C are reacted 6 hours, and reaction terminates, and be chilled to room temperature, then put into refrigerator and continue cooling 4 hours, cold-draw filters to obtain crude product.Dissolve crude product with saturated wet chemical, then drip concentrated hydrochloric acid, regulate pH value to 3-6, have flocculence produce raw in dropping process, dropwise latter standing 6 hours, suction filtration, washs to obtain crude product.Carry out recrystallization with water and ethanol 1:1.5 and obtain sterling 39.38g, productive rate 81.7%, fusing point: 110.5-112.0 DEG C, nuclear magnetic resonance spectroscopy:
1HNMR(400MHzCDCl3):11.0(s,1H),8.87(s,1H),7.62(d,J=8.0Hz,1H),7.48(s,1H), 7.37(q,J=8.0Hz,2H)。
Embodiment 3
2-amino-nicotinic acid (27.6g, 200mmol) and N-bromo-succinimide (NBS) (40.94g, 230mmol) make solvent with DMF, react 10 hours under subzero 35 degrees Celsius, obtained 2-amino-5-bromo-nicotinic acid; Rotary evaporation removes unnecessary solvent, adds the aqueous chloroacetaldehyde solution of 240mmol (47.10g) 40%, and 60 DEG C are reacted 12 hours, and reaction terminates, and be chilled to room temperature, then put into refrigerator and continue cooling 4 hours, cold-draw filters to obtain crude product.Dissolve crude product with saturated sodium bicarbonate aqueous solution, then drip concentrated hydrochloric acid, regulate pH value to 3-6, have flocculence produce raw in dropping process, dropwise latter standing 6 hours, suction filtration, washs to obtain crude product.Carry out recrystallization with water and ethanol 2:1 and obtain sterling 40.10g, productive rate 83.2%, fusing point: 110.5-112.0 DEG C, nuclear magnetic resonance spectroscopy:
1HNMR(400MHzCDCl3):11.0(s,1H),8.87(s,1H),7.62(d,J=8.0Hz,1H),7.48(s,1H), 7.37(q,J=8.0Hz,2H)。
Embodiment 4
2-amino-nicotinic acid (27.6g, 200mmol) and N-bromo-succinimide (NBS) (42.72g, 240mmol) acetonitrile as solvents, react 7 hours under subzero 15 degrees Celsius, obtained 2-amino-5-bromo-nicotinic acid; Rotary evaporation removes unnecessary etoh solvent, adds the aqueous chloroacetaldehyde solution of 250mmol (49.06g) 40%, and 70 DEG C are reacted 11 hours, and reaction terminates, and be chilled to room temperature, then put into refrigerator and continue cooling 4 hours, cold-draw filters to obtain crude product.Dissolve crude product with saturated aqueous sodium carbonate, then drip concentrated hydrochloric acid, regulate pH value to 3-6, have flocculence produce raw in dropping process, dropwise latter standing 6 hours, suction filtration, washs to obtain crude product.Carry out recrystallization with water and ethanol 1.5:1 and obtain sterling 36.44g, productive rate 75.6 %, fusing point: 110.5-112.0 DEG C, nuclear magnetic resonance spectroscopy:
1HNMR(400MHzCDCl3):11.0(s,1H),8.87(s,1H),7.62(d,J=8.0Hz,1H),7.48(s,1H), 7.37(q,J=8.0Hz,2H)。
Embodiment 5
2-amino-nicotinic acid (27.6g, 200mmol) and N-bromo-succinimide (NBS) (44.50g, 250mmol) make solvent by N,N-dimethylacetamide, react 6 hours under subzero 10 degrees Celsius, obtained 2-amino-5-bromo-nicotinic acid; Rotary evaporation removes unnecessary solvent, adds the aqueous chloroacetaldehyde solution of 260mmol (51.03g) 40%, and 80 DEG C are reacted 10 hours, and reaction terminates, and be chilled to room temperature, then put into refrigerator and continue cooling 4 hours, cold-draw filters to obtain crude product.Dissolve crude product with saturated aqueous sodium carbonate, then drip concentrated hydrochloric acid, regulate pH value to 3-6, have flocculence produce raw in dropping process, dropwise latter standing 6 hours, suction filtration, washs to obtain crude product.Carry out recrystallization with water and ethanol 1:2 and obtain sterling 26.64g, productive rate 55.27%, fusing point: 110.5-112.0 DEG C, nuclear magnetic resonance spectroscopy:
1HNMR(400MHzCDCl3):11.0(s,1H),8.87(s,1H),7.62(d,J=8.0Hz,1H),7.48(s,1H), 7.37(q,J=8.0Hz,2H)。
Embodiment 6
2-amino-nicotinic acid (27.6g, 200mmol) and N-bromo-succinimide (NBS) (44.50g, 250mmol) make solvent by N,N-dimethylacetamide, react 6 hours under subzero 10 degrees Celsius, obtained 2-amino-5-bromo-nicotinic acid; Rotary evaporation removes unnecessary solvent, adds the aqueous chloroacetaldehyde solution of 260mmol (51.03g) 40%, and 130 DEG C are reacted 8 hours, and reaction terminates, and be chilled to room temperature, then put into refrigerator and continue cooling 4 hours, cold-draw filters to obtain crude product.Dissolve crude product with saturated aqueous sodium carbonate, then drip concentrated hydrochloric acid, regulate pH value to 3-6, have flocculence produce raw in dropping process, dropwise latter standing 6 hours, suction filtration, washs to obtain crude product.Carry out recrystallization with water and ethanol 1:1 and obtain sterling 35.09g, productive rate 72.8%, fusing point: 110.5-112.0 DEG C, nuclear magnetic resonance spectroscopy:
1HNMR(400MHzCDCl3):11.0(s,1H),8.87(s,1H),7.62(d,J=8.0Hz,1H),7.48(s,1H), 7.37(q,J=8.0Hz,2H)。
Embodiment 7
2-amino-nicotinic acid (27.6g, 200mmol) and N-bromo-succinimide (44.50g, 250mmol) make solvent by N,N-dimethylacetamide, react 6 hours under subzero 10 degrees Celsius, obtained 2-amino-5-bromo-nicotinic acid; Rotary evaporation removes unnecessary solvent, adds the aqueous chloroacetaldehyde solution of 260mmol (51.03g) 40%, and 30 DEG C are reacted 11 hours, and reaction terminates, and be chilled to room temperature, then put into refrigerator and continue cooling 4 hours, cold-draw filters to obtain crude product.Dissolve crude product with saturated aqueous sodium carbonate, then drip concentrated hydrochloric acid, regulate pH value to 3-6, have flocculence produce raw in dropping process, dropwise latter standing 6 hours, suction filtration, washs to obtain crude product.Carry out recrystallization with water and ethanol 1:1.8 and obtain sterling 35.57g, productive rate 73.8%.
Embodiment 8
2-amino-nicotinic acid (27.6g, 200mmol) and N-bromo-succinimide (44.50g, 250mmol) N, N-N,N-DIMETHYLACETAMIDE makes solvent, 5ml water first reacts 5min at normal temperatures, then reacts 0.5 hour under subzero 15 degrees Celsius, obtained 2-amino-5-bromo-nicotinic acid; Rotary evaporation removes unnecessary solvent, adds the aqueous chloroacetaldehyde solution of 100g40%, and 100 DEG C are reacted 0.8 hour, and reaction terminates, and be chilled to room temperature, then put into refrigerator and continue cooling 4 hours, cold-draw filters to obtain crude product.Dissolve crude product with saturated aqueous sodium carbonate, then drip concentrated hydrochloric acid, regulate pH value to 3, have flocculence produce raw in dropping process, after dropwising, add water and ethanol 1:1.8 mixed solution 8ml leaves standstill 0.5 hour, suction filtration, washs to obtain crude product.Carry out recrystallization with water and ethanol 1:1.8 and obtain sterling 43.48g, productive rate 90.2%.
Claims (8)
1. the synthetic method of 6-bromine imidazo [1, a 2-a] pyridine-8-formic acid, is characterized in that: comprise the following steps:
(1) 2-amino-nicotinic acid and N-bromo-succinimide are in certain ratio, at certain solvent, react under subzero 8-35 degree Celsius, obtained 2-amino-5-bromo-nicotinic acid, and this intermediate does not need to purify;
(2) react at 30-130 DEG C generates 6-bromine imidazo [1,2-a] pyridine-8-formic acid with a certain proportion of monochloroacetaldehyde. hydrochloride, reaction terminates, and is down to room temperature, then puts into refrigerator and continues to lower the temperature, product precipitation, the thick product of low temperature suction filtration;
(3) this thick product water dissolves add alkali completely, then drips concentrated hydrochloric acid to pH value to 3-6, has flocculence produce raw, obtain crude product in dropping process; Use the sterling of water and ethanol certain proportion recrystallization again.
2. the preparation method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid according to claim 1, is characterized in that: said solvent is ethyl acetate, ethanol, DMF, acetonitrile and N,N-dimethylacetamide.
3. the preparation method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid according to claim 1 and 2, is characterized in that: said alkali is saleratus, salt of wormwood, sodium bicarbonate, sodium carbonate.
4. the preparation method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid according to claim 1 and 2, is characterized in that: said proper temperature is 40 DEG C, 50 DEG C, 60,70 DEG C and 80 DEG C.
5. the preparation method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid according to claim 1 and 2, is characterized in that: the certain proportion of said 2-amino-nicotinic acid and N-bromo-succinimide refers to 1:1.05,1:1.1,1:1.15,1:1.2,1:1.25.
6. the preparation method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid according to claim 1 and 2, is characterized in that: said 2-amino-5-bromo-nicotinic acid and monochloroacetaldehyde certain proportion are 1:1,1:1.15,1:1.2,1:1.25,1:3.
7. the preparation method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid according to claim 1 and 2, is characterized in that: the certain proportion of said water and ethanol is 1:1,1.5:1,2:1,1:1.5,1:2.
8. the preparation method of 6-bromine imidazo [1,2-a] pyridine-8-formic acid according to claim 1 and 2, it is characterized in that: step (1) reaction times is 3-10 hour, step (1) reaction times is 6-12 hour.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410846459.3A CN104557922A (en) | 2014-12-31 | 2014-12-31 | Synthetic method for 6-bromoimidazo[1,2-a]pyridine-8-carboxylic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410846459.3A CN104557922A (en) | 2014-12-31 | 2014-12-31 | Synthetic method for 6-bromoimidazo[1,2-a]pyridine-8-carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104557922A true CN104557922A (en) | 2015-04-29 |
Family
ID=53075088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410846459.3A Pending CN104557922A (en) | 2014-12-31 | 2014-12-31 | Synthetic method for 6-bromoimidazo[1,2-a]pyridine-8-carboxylic acid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104557922A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104892603A (en) * | 2015-06-17 | 2015-09-09 | 山东国润生物医药有限公司 | Synthetic method for 6-iodo-imidazo [1,2-a] pyridine-8-formic acid |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004092727A2 (en) * | 2003-04-11 | 2004-10-28 | Structural Genomix, Inc. | Compound libraries and methods for drug discovery |
| WO2009023253A2 (en) * | 2007-08-15 | 2009-02-19 | Arena Pharmaceuticals Inc. | IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO |
| CN102131806A (en) * | 2008-06-20 | 2011-07-20 | 百时美施贵宝公司 | Triazolopyridine compounds useful as kinase inhibitors |
| CN103772382A (en) * | 2014-03-04 | 2014-05-07 | 定陶县友帮化工有限公司 | 6-bromine-8-hydroxyl-imidazo (1, 2a) pyridine hydrochloride and synthetic method thereof |
| CN103788092A (en) * | 2014-03-04 | 2014-05-14 | 定陶县友帮化工有限公司 | Method for synthesizing 6-bromoimidazo [1,2-a] pyridine |
| WO2014080241A1 (en) * | 2012-11-21 | 2014-05-30 | Piramal Enterprises Limited | Imidazopyridine compounds and uses thereof |
-
2014
- 2014-12-31 CN CN201410846459.3A patent/CN104557922A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004092727A2 (en) * | 2003-04-11 | 2004-10-28 | Structural Genomix, Inc. | Compound libraries and methods for drug discovery |
| WO2009023253A2 (en) * | 2007-08-15 | 2009-02-19 | Arena Pharmaceuticals Inc. | IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO |
| CN102131806A (en) * | 2008-06-20 | 2011-07-20 | 百时美施贵宝公司 | Triazolopyridine compounds useful as kinase inhibitors |
| WO2014080241A1 (en) * | 2012-11-21 | 2014-05-30 | Piramal Enterprises Limited | Imidazopyridine compounds and uses thereof |
| CN103772382A (en) * | 2014-03-04 | 2014-05-07 | 定陶县友帮化工有限公司 | 6-bromine-8-hydroxyl-imidazo (1, 2a) pyridine hydrochloride and synthetic method thereof |
| CN103788092A (en) * | 2014-03-04 | 2014-05-14 | 定陶县友帮化工有限公司 | Method for synthesizing 6-bromoimidazo [1,2-a] pyridine |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104892603A (en) * | 2015-06-17 | 2015-09-09 | 山东国润生物医药有限公司 | Synthetic method for 6-iodo-imidazo [1,2-a] pyridine-8-formic acid |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104530090B (en) | A kind of preparation method of pyridine derivate | |
| CN105566215A (en) | Preparation method of Stivarga | |
| CN105294583A (en) | Synthesizing method of 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid | |
| CN104086545A (en) | Synthesis method of 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridyl-3-formamidine hydrochloride | |
| CN104557922A (en) | Synthetic method for 6-bromoimidazo[1,2-a]pyridine-8-carboxylic acid | |
| CN103896941A (en) | Synthesis method of 6-chloroimidazo[1,2-a]pyridine-3-formonitrile | |
| CN104402881B (en) | A kind of synthetic method of 3-aldehyde radical-6-bromine imidazo [1,2-a] pyridine-8-ethyl formate | |
| CN104650078A (en) | Synthesis method of 6-bromo-imidazo[1,2-a]pyridine-8-methanoic acid | |
| CN102936223A (en) | Synthesis method and purification method of 5-iodo-2-methylbenzimidazole | |
| CN104402882A (en) | Synthetic method of ethyl 3-aldehyde-6-chloroimidazo[1,2-a]pyridine-8-formate | |
| CN103613597A (en) | Preparation process of sildenafil citrate | |
| CN104876911A (en) | Simple method for synthesizing delafloxacin | |
| CN103965192B (en) | A kind of synthetic method of 6-chlorine imidazo [1,2-a] Nicotinicum Acidum | |
| CN102964356B (en) | Synthesis method of flucloxacillin sodium | |
| CN102731375A (en) | Synthesizing of 4,6-dichloro-5-pyrimidinecarbaldehyde | |
| CN102382071B (en) | Technology for preparing 1H-tetrazoleacetic acid with deamination reduction method | |
| CN104844598A (en) | Synthesis method of 8-methoxy ethyl formate imidazole and [1,2a]pyridine-3-ethyl formate | |
| CN104892603A (en) | Synthetic method for 6-iodo-imidazo [1,2-a] pyridine-8-formic acid | |
| CN103086962A (en) | Synthetic method for 5-chlorine-2,4-dyhydroxyl pyridine | |
| CN105037374B (en) | Preparation method of N-butyl-9H-pyrido[4,5-b]indole-2-carboxamide | |
| CN104876925A (en) | Synthesis method for 3-aldehyde imidazo-[1, 2-alpha] pyridine-8-ethyl formate | |
| CN103360307B (en) | Preparation method of 5-chloro-2,4-dihydroxypyridine | |
| CN103601671A (en) | Preparation method of iodo trifluoro methyl pyridine | |
| CN104725376A (en) | Synthetic method of 6-chlorine-8-carboxyl imidazo [1,2-a] pyridine | |
| CN101712602A (en) | Method for synthesizing 4,4'-biphenyldicarboxaldehyde by one-pot method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150429 |